PUR001 for Solid Tumors
This trial is testing a new cancer drug to see if it is safe and effective. The drug will be given to a small group of people to see what effects, if any, it has.
- Advanced Solid Tumors
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Does the study continue to accept participants?
"As indicated on clinicaltrials.gov, this research project is no longer recruiting participants. Initially posted in March 9th 2022 and last updated a few days before that, its closure has opened the doors for 2502 other experiments actively searching for candidates at present."
What assessments have been made to ensure the safety of PUR001 for individuals undergoing treatment?
"PUR001 has only been assessed in a Phase 1 trial, therefore Power's team assigned it with the lowest safety score of 1. This is due to its lack of data regarding efficacy and safety."